EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C31H38N2O7 |
| Net Charge | 0 |
| Average Mass | 550.652 |
| Monoisotopic Mass | 550.26790 |
| SMILES | CCCC[C@@H](C)/C=C(C)/C=C(\C)C(=O)NC1=C[C@@](O)(/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O |
| InChI | InChI=1S/C31H38N2O7/c1-5-6-11-19(2)16-20(3)17-21(4)30(38)32-22-18-31(39,29-28(40-29)27(22)37)15-10-8-7-9-12-25(36)33-26-23(34)13-14-24(26)35/h7-10,12,15-19,28-29,34,39H,5-6,11,13-14H2,1-4H3,(H,32,38)(H,33,36)/b8-7+,12-9+,15-10+,20-16+,21-17+/t19-,28-,29-,31+/m1/s1 |
| InChIKey | TWWQHCKLTXDWBD-MVTGTTCWSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Streptomyces parvulus (ncbitaxon:146923) | - | PubMed (8460134) | Strain: Tu64 |
| Streptomyces sp. (ncbitaxon:1931) | - | PubMed (15787434) | Strain: M045 |
| Roles Classification |
|---|
| Biological Roles: | bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. EC 1.8.1.9 (thioredoxin reductase) inhibitor An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of thioredoxin reductase (EC 1.8.1.9). EC 2.5.1.58 (protein farnesyltransferase) inhibitor An EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor that interferes with the action of protein farnesyltransferase (EC 2.5.1.58), one of the three enzymes in the prenyltransferase group. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| manumycin A (CHEBI:29623) has role antiatherosclerotic agent (CHEBI:145947) |
| manumycin A (CHEBI:29623) has role antimicrobial agent (CHEBI:33281) |
| manumycin A (CHEBI:29623) has role antineoplastic agent (CHEBI:35610) |
| manumycin A (CHEBI:29623) has role apoptosis inducer (CHEBI:68495) |
| manumycin A (CHEBI:29623) has role bacterial metabolite (CHEBI:76969) |
| manumycin A (CHEBI:29623) has role EC 1.8.1.9 (thioredoxin reductase) inhibitor (CHEBI:64670) |
| manumycin A (CHEBI:29623) has role EC 2.5.1.58 (protein farnesyltransferase) inhibitor (CHEBI:64133) |
| manumycin A (CHEBI:29623) has role marine metabolite (CHEBI:76507) |
| manumycin A (CHEBI:29623) is a enamide (CHEBI:51751) |
| manumycin A (CHEBI:29623) is a epoxide (CHEBI:32955) |
| manumycin A (CHEBI:29623) is a organic heterobicyclic compound (CHEBI:27171) |
| manumycin A (CHEBI:29623) is a polyketide (CHEBI:26188) |
| manumycin A (CHEBI:29623) is a secondary carboxamide (CHEBI:140325) |
| manumycin A (CHEBI:29623) is a tertiary alcohol (CHEBI:26878) |
| IUPAC Name |
|---|
| (2E,4E,6R)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyldeca-2,4-dienamide |
| Synonyms | Source |
|---|---|
| (2E,4E,6R)-N-[(1S,5S,6R)-5-Hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyl-2,4-decadienamide | ChEBI |
| manumycin | KEGG COMPOUND |
| (−)-manumycin A | ChEBI |
| manumycin A | KEGG COMPOUND |
| NSC 622141 | ChEBI |
| UCF1-C | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 4942813 | ChemSpider |
| C12111 | KEGG COMPOUND |
| CPD-18768 | MetaCyc |
| HMDB0242678 | HMDB |
| LMFA08020185 | LIPID MAPS |
| Registry Numbers | Sources |
|---|---|
| CAS:52665-74-4 | ChemIDplus |
| Citations |
|---|